Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation

Published:2014-08-28 Issue:12 Volume:63 Page:1261-1272
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Liu Wen-Juan,Liu Xiu-Jun,Li Liang,Li Yi,Zhang Sheng-Hua,Zhen Yong-Su

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-014-1604-1.pdf

Reference28 articles.

1. Fridkin M, Najjar VA (1989) Tuftsin: its chemistry, biology, and clinical potential. Crit Rev Biochem Mol Biol 24:1–40

2. Nishioka K (1979) Anti-tumour effect of the physiological tetrapeptide, tuftsin. Br J Cancer 39:342–345

3. Jain S, Amiji M (2012) Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system. Biomacromolecules 13:1074–1085

4. Nissen JC, Selwood DL, Tsirka SE (2013) Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway. J Neurochem 127:394–402

5. Khan A, Khan AA, Dwivedi V, Ahmad MG, Hakeem S, Owais M (2007) Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice. Mol Med 13:266–276

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuftsin-tailored fusion protein inhibits the growth of circulating gastric tumor cells associated with macrophage phagocytosis;Biochemistry and Biophysics Reports;2023-07

2. Drug resistance to targeted therapeutic strategies in non-small cell lung cancer;Pharmacology & Therapeutics;2020-02

3. Immunological evaluation of fusion protein of Brugia malayi abundant larval protein transcript-2 (BmALT-2) and Tuftsin in experimental mice model;Parasite Epidemiology and Control;2019-02

4. Enediyne-activated, EGFR-targeted human β-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma;Laboratory Investigation;2018-09-11

5. EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis;Acta Pharmacologica Sinica;2018-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3